EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

The majority of our real estate footprint for the next several years, we sold our hemophilia a program and related technology to Novo Nordisk for $40 million. We received FDA approval in the third ...

Ahead of World Diabetes Day on November 14, the Bangkok Ride & Run 2024 brought together hundreds in support of diabetes ...